Journal
CURRENT TREATMENT OPTIONS IN NEUROLOGY
Volume 21, Issue 12, Pages -Publisher
CURRENT MEDICINE GROUP
DOI: 10.1007/s11940-019-0605-y
Keywords
Treatment; Gene Therapy; Stem Cell Transplant; Cerebral; Adrenoleukodystrophy
Categories
Ask authors/readers for more resources
Purpose of review To present an updated appraisal of hematopoietic stem cell transplant (HSCT) and gene therapy for X-linked adrenoleukodystrophy (ALD) in the setting of a novel, presymptomatic approach to disease. Recent findings Outcomes in HSCT for ALD have been optimized over time due to early patient detection, improved myeloablative conditioning regimens, and adjunctive treatment for patients with advanced cerebral disease. Gene therapy has arrested disease progression in a cohort of boys with childhood cerebral ALD. New therapeutic strategies have provided the clinical basis for the implementation of Newborn Screening (NBS). With the help of advocacy groups, NBS has been implemented, allowing for MRI screening for the onset of cerebral ALD from birth. Gene therapy and optimized hematopoietic stem cell transplant for childhood CALD have changed the natural history of this previously devastating neurological disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available